Commit Biologics: Valuation, Funding & Investors
Commit Biologics is a biotechnology company focused on leveraging the activation of the complement system to develop innovative treatments for cancer and autoimmune diseases. The company is advancing its proprietary BiCE platform to identify and develop drug candidates, aiming to transform therapeutic approaches in these challenging medical areas.
Leadership & Board
- Current Number of Employees
- 33
- Current LinkedIn Followers
- 3,469
Latest Estimated Valuation
- Total Amount Raised
- $6M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $6M
- Latest Funding Round
- Seed Round
Employee Trend
Commit Biologics had 33 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
33Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Commit Biologics had 3,469 followers as of October 26, 2026. The number of followers increased by 16 (0.46%) week-over-week.
3,469Latest Followers Count
16(0.46%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 28, 2025 | Seed Round | $5.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Novo Holdings | Seed Round |
| Korys | Seed Round |
| Bioqube Ventures | Seed Round |
Similar Companies
A snapshot of private companies similar to Commit Biologics, helping you discover and navigate related company profiles.
